High complication rate after syndesmotic screw removal

Injury
Mette Renate AndersenWender Figved

Abstract

The aim of this study was to determine the rate of complications after routine syndesmotic screw removal. All patients who underwent syndesmotic screw removal at our hospital between 2007 and 2012 were included in the study. Patient demographics, surgical characteristics, radiographic evaluation and complications were recorded from the patients' charts. Questionnaires were sent by postal mail to all patients, to measure patient satisfaction and pain (VAS scales). 161 patients were included in the trial. A wound infection was found in 8 (5%) patients. 3 were regarded as serious infections requiring hospitalisation and intravenous antibiotics, 2 of those required surgical revisions. 5 patients were treated by oral antibiotics. Staphylococcus aureus was identified as the causing organism in all (6/8) cases with a positive culture. The patients with postoperative infection reported more pain (5.3 vs. 2.3; p=0.02) and were less satisfied (4.7 vs. 7.6; p=0.014) with their ankle compared to those without infection (T-test for independent samples). There were 5% wound infections after routine syndesmotic screw removal. Routine antibiotic prophylaxis effective against S. aureus should be administered when removing syndesmotic screws. In...Continue Reading

References

Jan 1, 1992·Injury·P L SandersonP G Turner
Dec 1, 2001·Bone·T P van StaaC Cooper
Mar 5, 2008·Injury·Michel P J van den BekeromC Niek van Dijk
Aug 5, 2009·The Journal of Bone and Joint Surgery. British Volume·N HamidM J Bosse
Dec 26, 2009·Journal of Orthopaedic Trauma·Anna N MillerDean G Lorich
Aug 3, 2010·The Journal of Bone and Joint Surgery. British Volume·C A Willis-OwenD K Martin
Dec 17, 2010·Archives of Orthopaedic and Trauma Surgery·T Schepers
May 5, 2011·Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA·Gen SuzukiJunnosuke Ryu
Feb 22, 2012·Foot & Ankle International·Tim SchepersMaarten Van der Elst
Feb 24, 2012·Journal of Orthopaedic Trauma·H Claude SagiRoy W Sanders
Nov 13, 2012·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Yoshio TakesueKatsunori Yanagihara
Feb 22, 2013·The Journal of Bone and Joint Surgery. American Volume·Mikko T OvaskaJan Lindahl
May 21, 2014·Scandinavian Journal of Medicine & Science in Sports·E KemlerF J G Backx
Mar 19, 2015·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Leon J WorthMichael J Richards

❮ Previous
Next ❯

Citations

Dec 29, 2016·Foot & Ankle Specialist·Kempland C WalleyJohn Y Kwon
Jan 4, 2018·The Journal of Bone and Joint Surgery. American Volume·Mette Renate AndersenWender Figved
Nov 27, 2018·The American Journal of Sports Medicine·Yoshiharu ShimozonoJohn G Kennedy
Apr 25, 2019·Foot & Ankle Specialist·Michelle T SugiCharalampos Zalavras
May 21, 2020·Journal of Orthopaedic Trauma·Jessica M KohringJohn P Ketz
Sep 21, 2018·JBJS Essential Surgical Techniques·Mette Renate Andersen, Wender Figved
Sep 6, 2020·Journal of Orthopaedic Trauma·Fay R K SandersTim Schepers
May 16, 2019·The Orthopedic Clinics of North America·Craig C Akoh, Phinit Phisitkul

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.